Insider buying
~$3K2,905 sh @ $1.02
Traded Mar 21, 2025 · filed 4 days later
An Alzamend Neuro director paid $3K out of pocket for Alzamend Neuro shares. 2 other people at Alzamend Neuro bought some too, in the same month.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Traded Mar 26, 2025 · Filed Mar 27, 2025
An Alzamend Neuro director paid $3.3K out of pocket for Alzamend Neuro shares. 2 other people at Alzamend Neuro bought some too, in the same month. Shares held went up 13% with this purchase.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
open market purchase
Code P — open-market or private purchase
~$3,285
Shares × reported transaction price
<$25K
+12.5%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
First purchase in 0 months
Confirmed open-market purchases by the same insider in the available history
No
Compared with 2 earlier confirmed purchases
3 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
104 days after results of Dec 12, 2024, 119 days before results of Jul 23, 2025
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | −7.3% | −9.1% | +1.8% |
| 30 days | −37.5% | −0.9% | −36.7% |
| 90 days | −69.4% | +10.1% | −79.5% |
| 180 days | −75.0% | +19.0% | −94.0% |
| 365 days | −88.9% | +13.7% | −102.6% |
Past results only. Not a forecast.
Insider buying
Traded Mar 21, 2025 · filed 4 days later
An Alzamend Neuro director paid $3K out of pocket for Alzamend Neuro shares. 2 other people at Alzamend Neuro bought some too, in the same month.
Insider buying
Traded Mar 21, 2025 · filed 3 days later
The CFO of Alzamend Neuro paid $5K out of pocket for Alzamend Neuro shares. 2 other people at Alzamend Neuro bought some too, in the same month. Shares held went up 926% with this purchase.
Insider buying
Traded Mar 20, 2025 · filed the same day
An Alzamend Neuro director paid $4.9K out of pocket for Alzamend Neuro shares. 2 other people at Alzamend Neuro bought some too, in the same month. Shares held went up 23% with this purchase.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.
William B. Horne, Director's past purchases, 90 days after disclosure: 5 buys, median −78.1 pts vs S&P 500, beat it 0 of 5 times. Past results, not a forecast.